EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mechanistic research and therapeutic prospects of alternative splicing in neurodegenerative diseases

Xiaolan Ran, Mei Wang, Juan Huang, Nanyu Kuang, Peng Tian, Jingjing Wu, Fei Feng, Yong Luo, Nanqu Huang

Ageing Research Reviews · 2026-06 · 118 · 103133

DOI: 10.1016/j.arr.2026.103133 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-06. Verfasst von Xiaolan Ran und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou 563000, China. Hauptthemen laut MEDLINE: Alternative Splicing, Neurodegenerative Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: Guizhou Province Science and Technology Foundation, National Natural Science Foundation of China, Health Commission of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One essential post-transcriptional regulatory mechanism that increases protein diversity in eukaryotes is alternative splicing. This process is crucial for maintaining nervous system function and is highly active in neurons. Dysregulation of alternative splicing is a common pathogenic factor in many neurodegenerative diseases. For example, splicing variants of tau protein and amyloid precursor protein are implicated in Alzheimer's disease; aberrant splicing of α-synuclein (SNCA) and upregulation of specific transcript variants of the Parkin (PARK2) gene occurs in Parkinson's disease; and aberrant splicing of Stathmin-2 (STMN2) pre-mRNA leads to the loss of axonal maintenance proteins in amyotrophic lateral sclerosis and frontotemporal dementia. This process is precisely regulated by trans-acting factors, a class of RBPs that specifically recognize and bind to cis-acting elements on precursor mRNA (pre-mRNA). These factors are primarily categorized into two major groups: serine/arginine-rich (SR) proteins and heterogeneous nuclear ribonucleoproteins (hnRNPs). Although hnRNPs and SR proteins have been shown to regulate neuronal alternative splicing, their complex regulatory networks and associated disease mechanisms remain incompletely understood, hindering the development of targeted therapies. This review summarizes the molecular mechanisms of alternative splicing and its regulatory features in neurodegenerative diseases. It also summarizes recent advances in splicing-based therapies and biomarkers, providing insights into disease mechanisms and therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingNeurodegenerative DiseasesHumansAnimals

Stichwörter der Autor:innen

Alternative splicingAlzheimer's diseaseNeurodegenerative diseasesParkinson's diseaseSplicing factorsTherapeutics

Autor:innen und Institutionen

  • Department of Neurology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou 563000, China.
  • Key Laboratory of Basic Pharmacology and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Guizhou 563000, China.
  • Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai 200433, China; Neuroimaging Research Branch, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD…
  • Department of Pathology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou 563000, China.
  • Department of Neurology, Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou 563000, China; Department of Geriatrics, Third Affiliated Hospital of Zunyi Medical U…

Förderung

  • Guizhou Province Science and Technology Foundation
  • National Natural Science Foundation of China
  • Health Commission of Guizhou Province
  • Guizhou Provincial Health Commission

Zitieren

APA

Ran, X., Wang, M., Huang, J., Kuang, N., Tian, P., Wu, J., Feng, F., Luo, Y., & Huang, N. (2026). Mechanistic research and therapeutic prospects of alternative splicing in neurodegenerative diseases. Ageing Research Reviews, 118, 103133. https://doi.org/10.1016/j.arr.2026.103133

Vancouver

Ran X, Wang M, Huang J, Kuang N, Tian P, Wu J, et al. Mechanistic research and therapeutic prospects of alternative splicing in neurodegenerative diseases. Ageing Research Reviews. 2026;118:103133. doi:10.1016/j.arr.2026.103133

BibTeX
@article{Ran2026,
  author = {Ran, Xiaolan and Wang, Mei and Huang, Juan and Kuang, Nanyu and Tian, Peng and Wu, Jingjing and Feng, Fei and Luo, Yong and Huang, Nanqu},
  title = {Mechanistic research and therapeutic prospects of alternative splicing in neurodegenerative diseases},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {118},
  pages = {103133},
  doi = {10.1016/j.arr.2026.103133}
}
Kostenlos starten →